Table 1 Demographic characteristics of participants for the first visit of this study
From: Trajectories of glycated hemoglobin of T2DM and progress of arterial stiffness: a prospective study
Total | Males | Females | P | |
|---|---|---|---|---|
N | 940 | 543 | 397 | |
Duration, mean (SD), month | 88.83 (81.48) | 79.00 (78.55) | 102.59 (83.61) | < 0.001 |
Age, mean (SD), year | 51.36 (11.93) | 48.97 (11.56) | 54.63 (11.66) | < 0.001 |
Smoke, n (%) | 259 (27.82) | 248 (46.01) | 11 (2.81) | < 0.001 |
Drink, n (%) | 385 (41.40) | 350 (64.94) | 35 (8.95) | < 0.001 |
Hypertension, n (%) | 347 (38.77) | 188 (36.08) | 159 (42.51) | 0.600 |
SBP, mean (SD), mmHg | 131.71 (17.22) | 131.54 (17.18) | 131.96 (17.29) | 0.713 |
High school or more, n (%) | 549 (58.40) | 351 (64.64) | 198 (49.87) | < 0.001 |
HbA1c, mean (SD), | 8.70 (2.18) | 8.73 (2.22) | 8.66 (2.12) | 0.615 |
Lipid-lowering medications, n (%) | 248 (27.71) | 144 (27.69) | 104 (27.73) | 1.000 |
baPWV, mean (SD), cm/s | 1548.87 (305.48) | 1514.69 (277.06) | 1595.61 (335.30) | < 0.001 |
HDL, mean (SD), mmol/L | 1.18 (0.28) | 1.11 (0.26) | 1.29 (0.29) | < 0.001 |
LDL, mean (SD), mmol/L | 3.03 (0.91) | 3.01 (0.89) | 3.05 (0.93) | 0.467 |
TC, mean (SD), mmol/L | 4.77 (1.18) | 4.70 (1.19) | 4.87 (1.16) | 0.029 |
TG, mean (SD), mmol/L | 2.13 (2.21) | 2.35 (2.43) | 1.84 (1.84) | 0.001 |
Glu, mean (SD), mmol/L | 9.62 (4.30) | 9.78 (4.27) | 9.39 (4.33) | 0.164 |
Weight, mean (SD), kg | 74.04 (14.18) | 80.10 (12.98) | 65.74 (11.26) | < 0.001 |
BMI, mean (SD), kg/m2 | 26.65 (3.94) | 27.07 (3.84) | 26.08 (4.01) | < 0.001 |
Height, mean (SD), m | 166.30 (8.77) | 171.90 (6.16) | 158.63 (5.33) | < 0.001 |